Mark Curran, Ph.D. is responsible for delivering the biomarker strategy, integrated patient solutions, big data analysis and development of companion diagnostics for the Immunology Therapeutic Area. His team works to incorporate emerging science and human genetics into new programs with the goal of creating personalized treatment approaches that are predictive of response. Mark’s deep scientific expertise, entrepreneurial passion and commitment to people development continues to strengthen Janssen Immunology leadership in this evolving area of focus.
Immunology and Genetics